Intuitive Surgical's COVID-19 downturn presents buying opportunity

Eric Oliver -   Print  |

The COVID-19 pandemic has been harsh to Intuitive Surgical dropping its stock price nearly 20 percent, however The Motley Fool thinks this is the perfect opportunity to buy into the company.

What you should know:

1. Because Intuitive's DaVinci device is heavily-used in elective procedures, the devicemaker's stock has taken a beating.

2. However, an aging population will mean the devices will still remain relevant once the COVID-19 pandemic subsidies.

3. Intuitive has room to weather an extended period of lost revenue because of proactive financial management, and once operations return to normal after initial demand for elective surgery subsidies, facilities are expected to resume purchasing surgical robots.

More articles on healthcare: 
ASCs could get financial relief under $2 trillion stimulus law — 4 things to know
Can ASCs help with the COVID-19 surge?
California's 750+ ASCs prepare to expand services for COVID-19 surge

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers